Feldt-Rasmussen U - Search Results

1

Pegvisomant treatment in a 4-year-old girl with neurofibromatosis type 1.

Main KM, Sehested A, Feldt-Rasmussen U. Main KM, et al. Horm Res. 2006;65(1):1-5. doi: 10.1159/000089486. Epub 2005 Nov 1. Horm Res. 2006. PMID: 16269873

2

Long-term follow-Up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr).

Lavard L, Sehested A, Brock Jacobsen B, Muller J, Perrild H, Feldt-Rasmussen U, Parma J, Vassart G. Lavard L, et al. Horm Res. 1999;51(1):43-6. doi: 10.1159/000023312. Horm Res. 1999. PMID: 10095169

3

Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study.

Schmiegelow M, Lassen S, Poulsen HS, Feldt-Rasmussen U, Schmiegelow K, Hertz H, Müller J. Schmiegelow M, et al. Clin Endocrinol (Oxf). 2000 Aug;53(2):191-7. doi: 10.1046/j.1365-2265.2000.01079.x. Clin Endocrinol (Oxf). 2000. PMID: 10931100

4

Consequences of stopping growth hormone (GH) therapy in young GH deficient patients with childhood onset disease.

Juul A, Vahl N, Jørgensen JO, Christiansen JS, Sneppen SB, Feldt-Rasmussen U, Skakkebaek NE. Juul A, et al. Growth Horm IGF Res. 1998 Feb;8 Suppl A:15-9. doi: 10.1016/s1096-6374(98)80003-8. Growth Horm IGF Res. 1998. PMID: 10993585 Clinical Trial.

5

Sweat secretion rates in growth hormone disorders.

Sneppen SB, Main KM, Juul A, Pedersen LM, Kristensen LO, Skakkebaek NE, Feldt-Rasmussen U. Sneppen SB, et al. Clin Endocrinol (Oxf). 2000 Nov;53(5):601-8. doi: 10.1046/j.1365-2265.2000.01141.x. Clin Endocrinol (Oxf). 2000. PMID: 11106921

6

Growth hormone response to a growth hormone-releasing hormone stimulation test in a population-based study following cranial irradiation of childhood brain tumors.

Schmiegelow M, Lassen S, Poulsen HS, Feldt-Rasmussen U, Schmiegelow K, Hertz H, Müller J. Schmiegelow M, et al. Horm Res. 2000;54(2):53-9. doi: 10.1159/000053232. Horm Res. 2000. PMID: 11251367

7

Total and free insulin-like growth factor I, insulin-like growth factor binding protein 3 and acid-labile subunit reflect clinical activity in acromegaly.

Sneppen SB, Lange M, Pedersen LM, Kristensen L LØ, Main KM, Juul A, Skakkebaek NE, Feldt-Rasmussen U. Sneppen SB, et al. Growth Horm IGF Res. 2001 Dec;11(6):384-91. doi: 10.1054/ghir.2001.0254. Growth Horm IGF Res. 2001. PMID: 11914026

8

An audit of the insulin-tolerance test in 255 patients with pituitary disease.

Lange M, Svendsen OL, Skakkebaek NE, Müller J, Juul A, Schmiegelow M, Feldt-Rasmussen U. Lange M, et al. Eur J Endocrinol. 2002 Jul;147(1):41-7. doi: 10.1530/eje.0.1470041. Eur J Endocrinol. 2002. PMID: 12088918

9

Cardiac effects of low-dose growth hormone replacement therapy in growth hormone-deficient adults. An 18-month randomised, placebo-controlled, double-blind study.

Sneppen SB, Steensgaard-Hansen F, Feldt-Rasmussen U. Sneppen SB, et al. Horm Res. 2002;58(1):21-9. doi: 10.1159/000063212. Horm Res. 2002. PMID: 12169777 Clinical Trial.

10

Fabry disease--a metabolic disorder with a challenge for endocrinologists?

Feldt-Rasmussen U, Rasmussen AK, Mersebach H, Rosenberg KM, Hasholt L, Sorensen SA. Feldt-Rasmussen U, et al. Horm Res. 2002;58(6):259-65. doi: 10.1159/000066443. Horm Res. 2002. PMID: 12446988 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

574 results

Search Page

Filters